Dermata Therapeutics, Inc. (DRMA)
1.21
+0.03
(+2.54%)
USD |
NASDAQ |
Mar 05, 16:00
1.18
-0.03
(-2.48%)
After-Hours: 20:00
Dermata Therapeutics Cash from Investing (TTM) : 0.00 for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Ekso Bionics Holdings, Inc. | -0.188M |
| Citius Pharmaceuticals, Inc. | -10.15M |
| Aptevo Therapeutics, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | -302.56M |
| Alnylam Pharmaceuticals, Inc. | 436.33M |